PhaseFolio
Sign in

Newsroom

Press and company news

Updates on PhaseFolio's research, product, and collaborations, with clear links to the underlying evidence and methodology.

PhaseFolio and EB Research Partnership announcement

Announcement · Nonprofit access program

PhaseFolio begins work with EB Research Partnership

EB Research Partnership will use PhaseFolio to examine valuation assumptions, compare scenarios, organize supporting evidence, and evaluate research programs at both the asset and portfolio level. Access is being provided on a complimentary basis through PhaseFolio’s nonprofit access program.

Read the announcement

This collaboration supports internal evaluation and workflow feedback. It does not imply EB Research Partnership’s endorsement or independent validation of PhaseFolio’s methodologies or outputs.

Company boilerplate

About PhaseFolio

PhaseFolio connects the public record of drug development (trial registries, regulatory decisions and company filings) into evidence that can be traced to its source. Atlas compares trial records field by field, with each value linked to the record and field it came from. Workspace keeps the evidence, assumptions and scenarios behind an asset case in one versioned record. Sentinel, for following what changes in chosen records, is in development.

Learn about PhaseFolio